Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Other-Long-Term-Assets" stands at 15.70 Billion Euros as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Sanofi SA's third quarter, the item "Other Long Term Assets" stands at 15.70 Billion EUR. This represents an increase of 1,189.33 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 22.50 Billion Euros compared to the value the year prior.
The 1 year change is 22.50 Billion Euros.
The 3 year change is 22.60 Billion Euros.
The 5 year change is 31.67 Billion Euros.
The 10 year change is 20.63 Billion Euros.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Assets | 280,205,508,085.11 |